Researchers develop high-performance cancer vaccine using novel microcapsules
New vaccines in development
COMMENTS
Impact of Vaccines; Health, Economic and Social Perspectives
Introduction "The impact of vaccination on the health of the world's peoples is hard to exaggerate. With the exception of safe water, no other modality has had such a major effect on mortality reduction and population growth" (Plotkin and Mortimer, 1988).The development of safe and efficacious vaccination against diseases that cause substantial morbidity and mortality has been one of the ...
Vaccine Effectiveness Studies in the Field
A recent test-negative design study in Canada showed positive findings regarding vaccine effectiveness with the BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against symptomatic disease with ...
Advances in vaccines: revolutionizing disease prevention
Metrics. Vaccines have revolutionized modern medicine by preventing infectious diseases and safeguarding public health. This Collection showcases cutting-edge research on advancements in vaccine ...
Vaccine Innovations
Vaccination is a powerful method of disease prevention that is relevant to people of all ages and in all countries, as the Covid-19 pandemic illustrates. Vaccination can improve people's chances ...
Vaccines
Vaccines articles from across Nature Portfolio. Vaccines are a clinical product that is composed of live or dead material from an infectious agent - bacterium, virus, fungus or parasite - that ...
Covid-19 Vaccines
The protective effects of vaccination and prior infection against severe Covid-19 are reviewed, with proposed directions for future research, including mucosal immunity and intermittent vaccine boo...
Efficacy of COVID-19 vaccines: From clinical trials to real life
Research and Development RBD Receptor binding domain NK (cells) Natural killer SARS-CoV-2 ... Since the mechanisms of action and undesirable effects of these vaccines are addressed in other articles of this special issue, we will focus on the efficacy of coronavirus disease 2019 (COVID-19) vaccines, more particularly on the four vaccines ...
Comparing the clinical efficacy of COVID-19 vaccines: a ...
The current research is the most comprehensive network meta-analysis to compare the efficacy of nine new COVID-19 vaccines to prevent symptomatic and severe disease in the adult population ...
Long-term effectiveness of COVID-19 vaccines against infections
Our analyses indicate that vaccine effectiveness generally decreases over time against SARS-CoV-2 infections, hospitalisations, and mortality. The baseline vaccine effectiveness levels for the omicron variant were notably lower than for other variants. Therefore, other preventive measures (eg, face-mask wearing and physical distancing) might be necessary to manage the pandemic in the long term.
Effectiveness of COVID‐19 vaccines: findings from real world studies
Community‐based studies in five countries show consistent strong benefits from early rollouts of COVID‐19 vaccines. By the beginning of June 2021, almost 11% of the world's population had received at least one dose of a coronavirus disease 2019 (COVID‐19) vaccine. 1 This represents an extraordinary scientific and logistic achievement — in 18 months, researchers, manufacturers and ...
Impact of Routine Childhood Immunization in Reducing Vaccine
Childhood vaccination has dramatically reduced morbidity, mortality, and disability caused by vaccine-preventable diseases, with ∼21 million hospitalizations, 732 000 deaths, and 322 million cases of disease averted in the United States between 1994 and 2013. 1 Among diseases targeted by vaccines recommended before 1980, 3—polio, measles, and rubella—have achieved elimination status as ...
COVID-19 Vaccines
By the end of November 2021, scientists estimate that mRNA COVID-19 vaccines had prevented at least 1 million deaths, 10 million hospitalizations, and 36 million SARS-CoV-2 infections in the United States. Sometimes people who are fully vaccinated get a breakthrough infection, meaning that they test positive for SARS-CoV-2 or become ill with ...
Vaccines News -- ScienceDaily
News on vaccines including HPV vaccine, shingles vaccine, bird flu vaccines and more. Read the latest research on vaccination risks and complications.
Scientists closing in on why some people never get COVID. That could
Age still best determines when to get COVID vaccines, new research suggests. 4 months ago. Duration 1:59. It's been four years since COVID-19 was declared a pandemic, and new research suggests ...
New Covid Shots Recommended for Americans 6 Months and Older This Fall
A vaccine by Novavax will target JN.1, the variant that prevailed for months in the winter and spring. The shots to be made by Pfizer and Moderna are aimed at KP.2, which until recently seemed ...
Understanding Vaccine Safety and the Roles of the FDA and the CDC
Understanding Vaccine Safety and the Roles of the FDA and the CDC. Author: H. Cody Meissner, M.D. Author Info & Affiliations. Published April 27, 2022. N Engl J Med 2022;386: 1638 - 1645. DOI: 10. ...
Federal Officials Revise Recommendations for R.S.V. Vaccine
The third, an mRNA vaccine called mRESVIA made by Moderna, was approved only this May. Officials said in February that the vaccines might have caused some cases of Guillain-Barré syndrome, a rare ...
COVID vaccines and safety: what the research says
There is no question that the current vaccines are effective and safe. The risk of severe reaction to a COVID-19 jab, say researchers, is outweighed by the protection it offers against the deadly ...
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age
For Americans who decide to get the latest COVID shots, there will be a choice among this year's vaccines: The Novavax shot will target JN.1, the variant that prevailed during the winter, while ...
As Covid cases rise, CDC recommends new version of vaccine
Earlier this month, the Food and Drug Administration — following the guidance of its own panel of expert advisers — told vaccine manufacturers to target the JN.1 version of the virus. But a ...
Lassa fever research priorities: towards effective medical
In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote development of effective medical countermeasures (ie, diagnostics, therapeutics, and vaccines) against Lassa fever. Diagnostic testing for Lassa fever has important limitations and key advancements are needed to ...
Early Release
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. ... Diseases supporting the operations of the University of Pittsburgh Regional Biocontainment Laboratory in the Center for Vaccine Research. H5N1 studies were performed in ...
Simply put: Vaccination saves lives
A recent economic analysis of 10 vaccines for 94 low- and middle-income countries estimated that an investment of $34 billion for the immunization programs resulted in savings of $586 billion in reducing costs of illness and $1.53 trillion when broader economic benefits were included ( 5 ). The only human disease ever eradicated, smallpox, was ...
Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents Show
Moderna Inc. shares sank after new data showed the efficacy of its RSV shot fell sharply in the second year and was lower than that of rival vaccines. The results could further raise doubts over ...
Communication of COVID-19 Misinformation on Social Media by Physicians
Claims that myocarditis was common in children who received the vaccine and that the risks of myocarditis outweighed the risk of vaccination were also unfounded. 23 Several physicians redistributed news articles with stories of individuals suddenly or mysteriously dying from the vaccine, despite evidence from the CDC confirming that deaths ...
Meet the Researcher: Elsio Wunder, CAHNR
Generally, once researchers understand the pathogenesis of a specific virus or bacteria, they can begin to develop better treatments and vaccines. But not much is understood about the pathogenesis of Leptospira. That's the gap Wunder is racing to close. "We do have a vaccine available worldwide for animals - dogs, pigs, cattle," Wunder ...
Pregnancy and COVID-19: What are the risks?
Barros, FC. Maternal vaccination against COVID-19 and neonatal outcomes during omicron: INTERCOVID-2022 study. American Journal of Obstetrics and Gynecology. 2024; doi: 10.1016/j.ajog.2024.02.008. Interim clinical considerations for use of COVID-19 vaccines in the United States.
Advancements in Fish Vaccination: Current Innovations and Future ...
Various review articles have extensively detailed the techniques employed in vaccine administration, current vaccination models, and the challenges confronting the fish vaccinology industry today [10,13,24]. Bearing these considerations in mind, we will delve into the trends in fish vaccination, explore different vaccine types and ...
A guide to vaccinology: from basic principles to new developments
A vaccine is a biological product that can be used to safely induce an immune response that confers protection against infection and/or disease on subsequent exposure to a pathogen. To achieve ...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with more than a 99 ...
IMAGES
COMMENTS
Introduction "The impact of vaccination on the health of the world's peoples is hard to exaggerate. With the exception of safe water, no other modality has had such a major effect on mortality reduction and population growth" (Plotkin and Mortimer, 1988).The development of safe and efficacious vaccination against diseases that cause substantial morbidity and mortality has been one of the ...
A recent test-negative design study in Canada showed positive findings regarding vaccine effectiveness with the BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against symptomatic disease with ...
Metrics. Vaccines have revolutionized modern medicine by preventing infectious diseases and safeguarding public health. This Collection showcases cutting-edge research on advancements in vaccine ...
Vaccination is a powerful method of disease prevention that is relevant to people of all ages and in all countries, as the Covid-19 pandemic illustrates. Vaccination can improve people's chances ...
Vaccines articles from across Nature Portfolio. Vaccines are a clinical product that is composed of live or dead material from an infectious agent - bacterium, virus, fungus or parasite - that ...
The protective effects of vaccination and prior infection against severe Covid-19 are reviewed, with proposed directions for future research, including mucosal immunity and intermittent vaccine boo...
Research and Development RBD Receptor binding domain NK (cells) Natural killer SARS-CoV-2 ... Since the mechanisms of action and undesirable effects of these vaccines are addressed in other articles of this special issue, we will focus on the efficacy of coronavirus disease 2019 (COVID-19) vaccines, more particularly on the four vaccines ...
The current research is the most comprehensive network meta-analysis to compare the efficacy of nine new COVID-19 vaccines to prevent symptomatic and severe disease in the adult population ...
Our analyses indicate that vaccine effectiveness generally decreases over time against SARS-CoV-2 infections, hospitalisations, and mortality. The baseline vaccine effectiveness levels for the omicron variant were notably lower than for other variants. Therefore, other preventive measures (eg, face-mask wearing and physical distancing) might be necessary to manage the pandemic in the long term.
Community‐based studies in five countries show consistent strong benefits from early rollouts of COVID‐19 vaccines. By the beginning of June 2021, almost 11% of the world's population had received at least one dose of a coronavirus disease 2019 (COVID‐19) vaccine. 1 This represents an extraordinary scientific and logistic achievement — in 18 months, researchers, manufacturers and ...
Childhood vaccination has dramatically reduced morbidity, mortality, and disability caused by vaccine-preventable diseases, with ∼21 million hospitalizations, 732 000 deaths, and 322 million cases of disease averted in the United States between 1994 and 2013. 1 Among diseases targeted by vaccines recommended before 1980, 3—polio, measles, and rubella—have achieved elimination status as ...
By the end of November 2021, scientists estimate that mRNA COVID-19 vaccines had prevented at least 1 million deaths, 10 million hospitalizations, and 36 million SARS-CoV-2 infections in the United States. Sometimes people who are fully vaccinated get a breakthrough infection, meaning that they test positive for SARS-CoV-2 or become ill with ...
News on vaccines including HPV vaccine, shingles vaccine, bird flu vaccines and more. Read the latest research on vaccination risks and complications.
Age still best determines when to get COVID vaccines, new research suggests. 4 months ago. Duration 1:59. It's been four years since COVID-19 was declared a pandemic, and new research suggests ...
A vaccine by Novavax will target JN.1, the variant that prevailed for months in the winter and spring. The shots to be made by Pfizer and Moderna are aimed at KP.2, which until recently seemed ...
Understanding Vaccine Safety and the Roles of the FDA and the CDC. Author: H. Cody Meissner, M.D. Author Info & Affiliations. Published April 27, 2022. N Engl J Med 2022;386: 1638 - 1645. DOI: 10. ...
The third, an mRNA vaccine called mRESVIA made by Moderna, was approved only this May. Officials said in February that the vaccines might have caused some cases of Guillain-Barré syndrome, a rare ...
There is no question that the current vaccines are effective and safe. The risk of severe reaction to a COVID-19 jab, say researchers, is outweighed by the protection it offers against the deadly ...
For Americans who decide to get the latest COVID shots, there will be a choice among this year's vaccines: The Novavax shot will target JN.1, the variant that prevailed during the winter, while ...
Earlier this month, the Food and Drug Administration — following the guidance of its own panel of expert advisers — told vaccine manufacturers to target the JN.1 version of the virus. But a ...
In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote development of effective medical countermeasures (ie, diagnostics, therapeutics, and vaccines) against Lassa fever. Diagnostic testing for Lassa fever has important limitations and key advancements are needed to ...
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. ... Diseases supporting the operations of the University of Pittsburgh Regional Biocontainment Laboratory in the Center for Vaccine Research. H5N1 studies were performed in ...
A recent economic analysis of 10 vaccines for 94 low- and middle-income countries estimated that an investment of $34 billion for the immunization programs resulted in savings of $586 billion in reducing costs of illness and $1.53 trillion when broader economic benefits were included ( 5 ). The only human disease ever eradicated, smallpox, was ...
Moderna Inc. shares sank after new data showed the efficacy of its RSV shot fell sharply in the second year and was lower than that of rival vaccines. The results could further raise doubts over ...
Claims that myocarditis was common in children who received the vaccine and that the risks of myocarditis outweighed the risk of vaccination were also unfounded. 23 Several physicians redistributed news articles with stories of individuals suddenly or mysteriously dying from the vaccine, despite evidence from the CDC confirming that deaths ...
Generally, once researchers understand the pathogenesis of a specific virus or bacteria, they can begin to develop better treatments and vaccines. But not much is understood about the pathogenesis of Leptospira. That's the gap Wunder is racing to close. "We do have a vaccine available worldwide for animals - dogs, pigs, cattle," Wunder ...
Barros, FC. Maternal vaccination against COVID-19 and neonatal outcomes during omicron: INTERCOVID-2022 study. American Journal of Obstetrics and Gynecology. 2024; doi: 10.1016/j.ajog.2024.02.008. Interim clinical considerations for use of COVID-19 vaccines in the United States.
Various review articles have extensively detailed the techniques employed in vaccine administration, current vaccination models, and the challenges confronting the fish vaccinology industry today [10,13,24]. Bearing these considerations in mind, we will delve into the trends in fish vaccination, explore different vaccine types and ...
A vaccine is a biological product that can be used to safely induce an immune response that confers protection against infection and/or disease on subsequent exposure to a pathogen. To achieve ...
A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with more than a 99 ...